About
Dr. Ryan Adami, DO, founded Xcelsior Health to deliver prevention-focused, data-driven primary care in Tampa, Florida. He earned his medical degree from Nova Southeastern University in 2005 and completed dual residency training in Internal Medicine and Pediatrics at the University of South Florida in 2009. He holds board certification in both Internal Medicine and Pediatrics.
Dr. Adami specializes in longevity medicine, metabolic health, cardiovascular risk, and hormonal health. He leads the Xcelsior Longevity Plus program and works directly with each patient enrolled in it. His clinical philosophy centers on evidence-based decisions driven by consistent biomarker data rather than assumption. He is passionate about the distinction between lifespan and healthspan, aiming to reduce years of decline rather than simply extend life. He produces educational content on topics including supplement safety and how health insurance differs from actual healthcare access.
Education & Training
Medical School
Nova Southeastern University, 2005
Residency
Dual Residency in Internal Medicine and Pediatrics, University of South Florida, completed 2009
Certifications
Conditions Treated
Who is Dr. Adami right for?
Dr. Adami is a strong fit for adults seeking proactive, data-driven primary care. Patients managing hypertension, diabetes, metabolic syndrome, cardiovascular risk, or hormonal imbalances benefit from his clinical depth. He is particularly well-suited to patients enrolled in Longevity Plus who want biomarker tracking, performance assessments, and ongoing physician guidance. His dual board certification also makes him an excellent choice for families with children and adult members who want a single trusted physician.
Similar Doctors Nearby
Dr. Benjamin MenaMD, FACP
diabetes, hypertension, obesity +1 more
Dr. John LippelmanMD
hypertension, diabetes, obesity +4 more
Dr. Bill McGroganMD
chronic disease, hypertension, diabetes +3 more
Frequently Asked Questions
Dr. Adami treats a broad range of conditions including hypertension, diabetes, metabolic syndrome, cardiovascular disease, hormonal imbalances, and thyroid disorders. He also manages ongoing chronic conditions for patients of all ages. His dual training in Internal Medicine and Pediatrics allows him to care for both adult and pediatric patients.
Yes. Dr. Adami holds board certification in both Internal Medicine and Pediatrics. He completed dual residency training at the University of South Florida in 2009 after earning his medical degree from Nova Southeastern University in 2005.
Dr. Adami practices evidence-based, data-driven medicine. He focuses on making clinical decisions from consistent biomarker data rather than assumptions or limited annual snapshots. His goal is to compress morbidity, meaning he works to reduce the years of decline at the end of life, not simply extend lifespan.
Yes. Dr. Adami personally oversees every patient in the Longevity Plus program. He reviews advanced biomarker results, interprets fitness and performance assessments, and guides each patient's personalized health strategy directly.
Dr. Adami focuses on preventive medicine, longevity optimization, metabolic health, cardiovascular risk reduction, and hormonal health. He also provides full-scope primary care and family medicine, including pediatric care.
Dr. Adami earned his DO degree from Nova Southeastern University in 2005. He then completed a dual residency in Internal Medicine and Pediatrics at the University of South Florida, finishing in 2009.
Yes. Dr. Adami is board certified in Pediatrics in addition to Internal Medicine. Xcelsior Health's membership plans accommodate children, and families can see Dr. Adami for both adult and pediatric care needs.
Dr. Adami built the Longevity Plus program specifically to eliminate guesswork from preventive care. He tests key biomarkers three times per year, integrates wearable data, and uses AI-enhanced insights from sources like PubMed, NEJM, and JAMA. Every decision for Longevity Plus patients draws from that consistent, personalized data set.
Doctor profile last updated March 23, 2026